| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| VBI Vaccines Inc/BC | Chief Commercial Officer | Option (Right to Buy Common Shares) | 52,500 | 27 Jul 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000149315223025956-dillman-john-robert-2023-07-27 | VBI Vaccines Inc/BC | 27 Jul 2023 | 1 | $0 | 4 | Chief Commercial Officer | 28 Jul 2023, 18:30 |
| /report/000149315223002982-dillman-john-robert-2023-01-26 | VBI Vaccines Inc/BC | 26 Jan 2023 | 1 | $0 | 4 | Chief Commercial Officer | 30 Jan 2023, 16:02 |
| /report/000149315222019097-dillman-john-robert-2022-07-07 | VBI Vaccines Inc/BC | 07 Jul 2022 | 1 | $0 | 4 | Chief Commercial Officer | 12 Jul 2022, 18:20 |
| /report/000149315222019095-dillman-john-robert-2022-07-07 | VBI Vaccines Inc/BC | 07 Jul 2022 | 0 | $0 | 3 | Chief Commercial Officer | 12 Jul 2022, 18:17 |